ROSENWALD LINDSAY A MD

Director · Officer · Ten-percent owner · DERM, FBIO, CKPT

As of 2026-09-16, ROSENWALD LINDSAY A MD has 10 Form 4 transactions on record across 3 companies — 2 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $12.9MIndirect: $0$12.9Mas of 2026-09-16
  • Direct $12.9M
  • Indirect $0
FBIOdirect4,586,841 sh$11.3M
DERMdirect221,146 sh$1.6M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

CKPT · 5 trades
2025-05-30: Code U, 207,007 sh2025-05-30: Code U, 207,007 sh2025-05-29: Award / grant, 50,000 sh ($65K)2025-05-28: Award / grant, 12,195 sh ($0)2024-12-13: Award / grant, 12,638 sh ($0)
DERM · 3 trades
2026-06-25: Award / grant, 10,000 sh ($0)2025-08-05: Award / grant, 50,000 sh ($0)2025-06-25: Award / grant, 7,173 sh ($0)
FBIO · 2 trades
2026-03-18: Award / grant, 475,424 sh ($0)2025-01-01: Award / grant, 454,153 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-25DERMAward / grant10,000221,146Form 4
2026-03-18FBIOAward / grant475,4244,586,841Form 4
2025-08-05DERMAward / grant50,000211,146Form 4
2025-06-25DERMAward / grant7,173161,146Form 4
2025-05-30CKPTCode U207,0070Form 4
2025-05-30CKPTCode U207,0070Form 4
2025-05-29CKPTAward / grant50,000207,007Form 4
2025-05-28CKPTAward / grant12,195157,007Form 4
2025-01-01FBIOAward / grant454,1534,111,417Form 4
2024-12-13CKPTAward / grant12,638144,812Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.